As the world increasingly moves towards digitization, electronic Product Information (ePI) is becoming a vital aspect of pharmaceutical innovation. The map of ePI activity in October 2024 reveals varied levels of adoption and scaling across different regions. Let’s dive into the global status of ePI implementation, grouping countries based on their progress.

Several countries and regions have advanced to the stage of scaling up ePI efforts, signifying mature implementations:
Middle East and Africa: Saudi Arabia, Egypt, South Africa, and Botswana have advanced to scaling up ePI.
Other regions are taking the initial steps by piloting ePI systems:
Asia: China is running an ePI pilot, while Japan is already operational with a paperless system.
In some regions, advocacy and legislative changes are paving the way for ePI adoption:
European Union: Revised legislation includes clear milestones for de-labeling, emphasizing a structured approach to ePI adoption.
A select group of countries is leading the charge in fully digital ePI implementation by removing paper leaflets and adopting sustainable, paperless systems:
The shift towards ePI systems reflects a broader trend of digital transformation in healthcare. Scaling up ePI promises greater efficiency, sustainability, and improved access to updated product information. However, the map also highlights the disparities in adoption, with some regions progressing rapidly while others remain in the early phases. This global snapshot serves as a call to action for continued collaboration, innovation, and investment to ensure equitable access to ePI across all regions.
We use technical cookies to run this site. With your consent we also use Google Analytics cookies to measure visits. We do not use advertising cookies. You can change your choice at any time from “Cookie settings” at the bottom of each page. Privacy and cookie policy